Literature DB >> 25699137

Conjugation and Evaluation of Small Hydrophobic Molecules to Triazole-Linked siRNAs.

Brandon J Peel1, Gordon Hagen1, Kalaivani Krishnamurthy1, Jean-Paul Desaulniers1.   

Abstract

Short interfering RNAs (siRNAs) have tremendous potential as a new class of next-generation therapeutics; however, their progress is lagging due to issues related to stability, biodistribution, and cell-membrane permeability. To overcome these issues, there is widespread interest in chemically modifying siRNAs. In this study, siRNAs that contain a triazole-backbone unit with pyrimidine-modified hydrophobic substituents were synthesized and examined for their gene-silencing activity. In our study, we generated a library of siRNAs that target both a plasmid reporter system and an endogenous gene target, bcl-2. Our results indicate that these unique modifications are well tolerated within the RNA interference pathway. In addition, a cholesterol-modified triazole-linked siRNA targeting the exogenous target firefly luciferase was capable of gene-silencing at levels greater than 80% in the absence of a carrier complex.

Entities:  

Keywords:  Short interfering RNAs; down regulation; gene expression; nucleic acid chemistry; oligonucleotides

Year:  2014        PMID: 25699137      PMCID: PMC4329592          DOI: 10.1021/ml500260j

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  32 in total

1.  A biochemical framework for RNA silencing in plants.

Authors:  Guiliang Tang; Brenda J Reinhart; David P Bartel; Phillip D Zamore
Journal:  Genes Dev       Date:  2003-01-01       Impact factor: 11.361

2.  Cleavage of the siRNA passenger strand during RISC assembly in human cells.

Authors:  Philipp J F Leuschner; Stefan L Ameres; Stephanie Kueng; Javier Martinez
Journal:  EMBO Rep       Date:  2006-01-20       Impact factor: 8.807

Review 3.  Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy.

Authors:  Peter E Czabotar; Guillaume Lessene; Andreas Strasser; Jerry M Adams
Journal:  Nat Rev Mol Cell Biol       Date:  2014-01       Impact factor: 94.444

Review 4.  Chemistry and formulations for siRNA therapeutics.

Authors:  Andrzej Gallas; Cameron Alexander; Martyn C Davies; Sanyogitta Puri; Stephanie Allen
Journal:  Chem Soc Rev       Date:  2013-10-21       Impact factor: 54.564

5.  Silencing activity of 2'-O-methyl modified anti-MDR1 siRNAs with mismatches in the central part of the duplexes.

Authors:  Natalya S Petrova; Mariya I Meschaninova; Alya G Venyaminova; Marina A Zenkova; Valentin V Vlassov; Elena L Chernolovskaya
Journal:  FEBS Lett       Date:  2011-06-23       Impact factor: 4.124

6.  Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans.

Authors:  A Fire; S Xu; M K Montgomery; S A Kostas; S E Driver; C C Mello
Journal:  Nature       Date:  1998-02-19       Impact factor: 49.962

7.  Argonaute2 cleaves the anti-guide strand of siRNA during RISC activation.

Authors:  Tim A Rand; Sean Petersen; Fenghe Du; Xiaodong Wang
Journal:  Cell       Date:  2005-11-03       Impact factor: 41.582

8.  Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs.

Authors:  Jürgen Soutschek; Akin Akinc; Birgit Bramlage; Klaus Charisse; Rainer Constien; Mary Donoghue; Sayda Elbashir; Anke Geick; Philipp Hadwiger; Jens Harborth; Matthias John; Venkitasamy Kesavan; Gary Lavine; Rajendra K Pandey; Timothy Racie; Kallanthottathil G Rajeev; Ingo Röhl; Ivanka Toudjarska; Gang Wang; Silvio Wuschko; David Bumcrot; Victor Koteliansky; Stefan Limmer; Muthiah Manoharan; Hans-Peter Vornlocher
Journal:  Nature       Date:  2004-11-11       Impact factor: 49.962

9.  Covalent conjugation of oligonucleotides with cell-targeting ligands.

Authors:  Md Rowshon Alam; Xin Ming; Osamu Nakagawa; Jian Jin; R L Juliano
Journal:  Bioorg Med Chem       Date:  2013-06-01       Impact factor: 3.641

10.  Carrier-free cellular uptake and the gene-silencing activity of the lipophilic siRNAs is strongly affected by the length of the linker between siRNA and lipophilic group.

Authors:  Natalya S Petrova; Ivan V Chernikov; Mariya I Meschaninova; Iiya S Dovydenko; Aliya G Venyaminova; Marina A Zenkova; Valentin V Vlassov; Elena L Chernolovskaya
Journal:  Nucleic Acids Res       Date:  2011-11-10       Impact factor: 16.971

View more
  5 in total

1.  SiRNAs with Neutral Phosphate Triester Hydrocarbon Tails Exhibit Carrier-Free Gene-Silencing Activity.

Authors:  Matthew L Hammill; Kouta Tsubaki; Lidya Salim; Andrew J Varley; Ifrodet Giorgees; Mitsuru Kitamura; Tatsuo Okauchi; Jean-Paul Desaulniers
Journal:  ACS Med Chem Lett       Date:  2022-03-14       Impact factor: 4.632

Review 2.  Modified Nucleic Acids: Expanding the Capabilities of Functional Oligonucleotides.

Authors:  Steven Ochoa; Valeria T Milam
Journal:  Molecules       Date:  2020-10-13       Impact factor: 4.411

3.  Effective carrier-free gene-silencing activity of cholesterol-modified siRNAs.

Authors:  Lidya Salim; Chris McKim; Jean-Paul Desaulniers
Journal:  RSC Adv       Date:  2018-06-22       Impact factor: 3.361

Review 4.  Triazole-Modified Nucleic Acids for the Application in Bioorganic and Medicinal Chemistry.

Authors:  Dagmara Baraniak; Jerzy Boryski
Journal:  Biomedicines       Date:  2021-05-31

5.  siRNAmod: A database of experimentally validated chemically modified siRNAs.

Authors:  Showkat Ahmad Dar; Anamika Thakur; Abid Qureshi; Manoj Kumar
Journal:  Sci Rep       Date:  2016-01-28       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.